Valérie Pimpaneau

As Vice President at VCLS, Valerie is responsible for leading the CMC Group in the design and optimization of CMC strategies adapted to the stage of product development and aligned with the relevant regulatory requirements and innovative pathways. This service covers conventional small molecules, biologics and gene and cell therapy products and includes the provision of advice on all regulatory and technical aspects of biotechnology product development.